Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 15-Jun-23 4:09 PM View:  | Codexis, Inc. (CDXS) | 13-Jun-23 | Grant | 34,602 | -- | -- | 102% 33.97K to 68.58K | |
| 24-Mar-23 8:19 PM View: | Allogene Therapeutics, Inc. (ALLO) | 22-Mar-23 | Grant | 558,094 | -- | -- | 487% 114.64K to 672.73K | |
| 16-Mar-23 10:00 PM View: | Allogene Therapeutics, Inc. (ALLO) | 14-Mar-23 | Payment of Exercise | 8,351 | $5.51 | $45,989.80 | (7%) 122.99K to 114.64K | |
| 16-Jun-22 4:10 PM View: | Codexis, Inc. (CDXS) | 14-Jun-22 | Grant | 11,273 | -- | -- | 50% 22.7K to 33.97K | |
| 17-Mar-22 5:58 PM View: | Allogene Therapeutics, Inc. (ALLO) | 15-Mar-22 | Sale | 8,698 | $7.63 | $66,388.40 | (7%) 129.13K to 120.43K | |
| 17-Jun-21 4:15 PM View: | Codexis, Inc. (CDXS) | 15-Jun-21 | Grant | 4,796 | -- | -- | 27% 17.91K to 22.7K | |
| 30-Mar-21 4:53 PM View: | Allogene Therapeutics, Inc. (ALLO) | 26-Mar-21 | Grant | 24,866 | -- | -- | 24% 102.57K to 127.44K | |
| 17-Mar-21 5:00 PM View: | Allogene Therapeutics, Inc. (ALLO) | 15-Mar-21 | Market Sale | 6,164 | $38.14 | $235,089.00 | (6%) 108.74K to 102.57K | (< 1%) |
| 13-Oct-20 4:34 PM View: | Allogene Therapeutics, Inc. (ALLO) | 13-Oct-20 | Option Exercise | 11,031 | $2.27 | $25,040.40 | 10% 108.37K to 119.4K | |
| 13-Oct-20 4:34 PM View: | Allogene Therapeutics, Inc. (ALLO) | 13-Oct-20 | Market Option Sale (Planned) | 11,031 | $42.00 | $463,302.00 | (9%) 119.4K to 108.37K | 34% |
| 13-Oct-20 4:34 PM View: | Allogene Therapeutics, Inc. (ALLO) | 12-Oct-20 | Option Exercise | 24,233 | $2.27 | $55,008.90 | 22% 108.37K to 132.6K | |
| 13-Oct-20 4:34 PM View: | Allogene Therapeutics, Inc. (ALLO) | 12-Oct-20 | Market Option Sale (Planned) | 24,233 | $42.00 | $1,017,790.00 | (18%) 132.6K to 108.37K | 34% |
| 09-Oct-20 5:49 PM View: | Allogene Therapeutics, Inc. (ALLO) | 09-Oct-20 | Option Exercise | 30,199 | $2.27 | $68,551.70 | 26% 117.68K to 147.88K | |
| 09-Oct-20 5:49 PM View: | Allogene Therapeutics, Inc. (ALLO) | 09-Oct-20 | Market Option Sale (Planned) | 30,199 | $41.00 | $1,238,160.00 | (20%) 147.88K to 117.68K | 33% |
| 09-Oct-20 5:49 PM View: | Allogene Therapeutics, Inc. (ALLO) | 09-Oct-20 | Market Sale (Planned) | 9,310 | $41.00 | $381,710.00 | (8%) 117.68K to 108.37K | 33% |
| 09-Oct-20 5:49 PM View: | Allogene Therapeutics, Inc. (ALLO) | 08-Oct-20 | Option Exercise | 5,065 | $2.27 | $11,497.50 | 4% 117.68K to 122.75K | |
| 09-Oct-20 5:49 PM View: | Allogene Therapeutics, Inc. (ALLO) | 08-Oct-20 | Market Option Sale (Planned) | 5,065 | $41.00 | $207,665.00 | (4%) 122.75K to 117.68K | 33% |
| 08-Oct-20 5:03 PM View: | Allogene Therapeutics, Inc. (ALLO) | 06-Oct-20 | Option Exercise | 35,264 | $2.27 | $80,049.30 | 28% 126.99K to 162.25K | |
| 08-Oct-20 5:03 PM View: | Allogene Therapeutics, Inc. (ALLO) | 06-Oct-20 | Market Option Sale (Planned) | 35,264 | $40.00 | $1,410,560.00 | (22%) 162.25K to 126.99K | 31% |
| 08-Oct-20 5:03 PM View: | Allogene Therapeutics, Inc. (ALLO) | 06-Oct-20 | Market Sale (Planned) | 9,310 | $40.00 | $372,400.00 | (7%) 126.99K to 117.68K | 31% |
| 14-Aug-20 4:04 PM View: | Allogene Therapeutics, Inc. (ALLO) | 13-Aug-20 | Option Exercise | 32,451 | $2.27 | $73,663.80 | 35% 93.82K to 126.27K | |
| 18-Jun-20 4:10 PM View: | Codexis, Inc. (CDXS) | 16-Jun-20 | Grant | 17,905 | -- | -- | 100% 0 to 17.91K | |
| 20-Mar-20 4:37 PM View: | Allogene Therapeutics, Inc. (ALLO) | 18-Mar-20 | Grant | 30,800 | -- | -- | 49% 63.02K to 93.82K | |
| 18-Mar-20 4:32 PM View: | Allogene Therapeutics, Inc. (ALLO) | 16-Mar-20 | Market Sale | 3,750 | $19.19 | $71,980.10 | (6%) 66.77K to 63.02K | (44%) |
| 18-Sep-19 7:05 PM View: | Allogene Therapeutics, Inc. (ALLO) | 18-Sep-19 | Option Exercise | 21,067 | $2.27 | $47,822.10 | 32% 66.07K to 87.13K | |
| 18-Sep-19 7:05 PM View: | Allogene Therapeutics, Inc. (ALLO) | 18-Sep-19 | Market Option Sale (Planned) | 21,067 | $32.13 | $676,872.00 | (24%) 87.13K to 66.07K | 14% |
| 18-Sep-19 7:05 PM View: | Allogene Therapeutics, Inc. (ALLO) | 17-Sep-19 | Option Exercise | 22,503 | $2.27 | $51,081.80 | 34% 66.07K to 88.57K | |
| 18-Sep-19 7:05 PM View: | Allogene Therapeutics, Inc. (ALLO) | 17-Sep-19 | Market Option Sale (Planned) | 22,503 | $32.11 | $722,560.00 | (25%) 88.57K to 66.07K | 14% |
| 18-Sep-19 7:05 PM View: | Allogene Therapeutics, Inc. (ALLO) | 16-Sep-19 | Option Exercise | 5,257 | $2.27 | $11,933.40 | 8% 66.07K to 71.32K | |
| 18-Sep-19 7:05 PM View: | Allogene Therapeutics, Inc. (ALLO) | 16-Sep-19 | Market Option Sale (Planned) | 5,257 | $32.00 | $168,234.00 | (7%) 71.32K to 66.07K | 14% |
| 30-Jul-19 6:23 PM View: | Allogene Therapeutics, Inc. (ALLO) | 30-Jul-19 | Option Exercise | 11,819 | $2.27 | $26,829.10 | 18% 65.37K to 77.19K | |
| 30-Jul-19 6:23 PM View: | Allogene Therapeutics, Inc. (ALLO) | 30-Jul-19 | Market Option Sale (Planned) | 11,819 | $29.84 | $352,738.00 | (15%) 77.19K to 65.37K | 8% |
| 30-Jul-19 6:23 PM View: | Allogene Therapeutics, Inc. (ALLO) | 29-Jul-19 | Option Exercise | 23,815 | $2.27 | $54,060.10 | 36% 65.37K to 89.19K | |
| 30-Jul-19 6:23 PM View: | Allogene Therapeutics, Inc. (ALLO) | 29-Jul-19 | Market Option Sale (Planned) | 23,815 | $29.39 | $699,870.00 | (27%) 89.19K to 65.37K | 6% |
| 30-Jul-19 6:23 PM View: | Allogene Therapeutics, Inc. (ALLO) | 26-Jul-19 | Option Exercise | 13,193 | $2.27 | $29,948.10 | 20% 65.37K to 78.57K | |
| 30-Jul-19 6:23 PM View: | Allogene Therapeutics, Inc. (ALLO) | 26-Jul-19 | Market Option Sale (Planned) | 13,193 | $29.18 | $384,994.00 | (17%) 78.57K to 65.37K | 6% |
| 01-Jul-19 4:32 PM View: | Allogene Therapeutics, Inc. (ALLO) | 28-Jun-19 | Option Exercise | 27,816 | $2.27 | $63,142.30 | 74% 37.56K to 65.37K | |
| 05-Jun-19 5:49 PM View: | Allogene Therapeutics, Inc. (ALLO) | 03-Jun-19 | Option Exercise | 48,828 | $2.27 | $110,840.00 | 130% 37.56K to 86.39K | |
| 05-Jun-19 5:49 PM View: | Allogene Therapeutics, Inc. (ALLO) | 03-Jun-19 | Market Option Sale (Planned) | 48,828 | $26.76 | $1,306,770.00 | (57%) 86.39K to 37.56K | (3%) |
| 15-Mar-19 5:22 PM View: | Allogene Therapeutics, Inc. (ALLO) | 13-Mar-19 | Grant | 37,050 | -- | -- | 100% 0 to 37.05K |